Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study

OBJECTIVE: To evaluate the efficacy and safety of conversion to lacosamide 400 mg/day monotherapy in adults with focal epilepsy. METHODS: This historical-controlled, double-blind study (NCT00520741) enrolled patients aged 16–70 years on stable doses of 1–2 antiepileptic drugs (AEDs) and experiencing...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Epilepsia
Autors principals: Wechsler, Robert T, Li, George, French, Jacqueline, O'Brien, Terence J, D'Cruz, O'Neill, Williams, Paulette, Goodson, Robin, Brock, Melissa
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2014
Matèries:
Full-Length Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477913/
https://ncbi.nlm.nih.gov/pubmed/24915838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.12681
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars